Low free testosterone is an independent risk factor for Alzheimer's disease.
about
A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.The benefits and risks of testosterone replacement therapy: a reviewA Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease PathogenesisThe endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive diseaseHypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: more than "just" estrogenLuteinizing hormone receptor mediates neuronal pregnenolone production via up-regulation of steroidogenic acute regulatory protein expressionInteraction of APOE genotype and testosterone on episodic memory in middle-aged men.Androgen receptor gene and sex-specific Alzheimer's disease.Estrogen: a master regulator of bioenergetic systems in the brain and bodyDown-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits.Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women.Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic miceBrain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.Androgen Deprivation Therapy and Future Alzheimer's Disease RiskEndocrine disruptors as a threat to neurological function.Handgrip strength and cognitive decline in older Mexican Americans.Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged menBrain and cognition abnormalities in long-term anabolic-androgenic steroid users.Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome.Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence.Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD miceCan endocrine disruptors influence neuroplasticity in the aging brain?Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.Luteinizing hormone: Evidence for direct action in the CNSAndrogen cell signaling pathways involved in neuroprotective actions.Effects of epsilon4 on object recognition in the non-demented elderly.Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats.Androgens and male aging: Current evidence of safety and efficacy.Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease?Genetic and environmental influences of daily and intra-individual variation in testosterone levels in middle-aged menSex hormone binding globulin and verbal memory in older men.Effects of dihydrotestosterone on synaptic plasticity of the hippocampus in mild cognitive impairment male SAMP8 mice.What are critical outcome measures for patients receiving pituitary replacement following brain injury?Testosterone replacement attenuates cognitive decline in testosterone-deprived lean rats, but not in obese rats, by mitigating brain oxidative stress.The worldwide challenge of the dementias: a role for B vitamins and homocysteine?Are declining testosterone levels a major risk factor for ill-health in aging men?Pharmacologic approaches to the aging athlete.Road to Alzheimer's disease: the pathomechanism underlying.Neuroendocrinology-based therapy for Alzheimer's disease.
P2860
Q21261427-0318D3B8-3C51-4E07-B3C8-DB864D635392Q24658011-0E08354F-5643-4CBA-A1B6-986756EBFB27Q26781496-123D7EDA-0276-45DF-AE5A-4E535AD8EE63Q26799258-106CFAC3-0FFC-4AFA-897E-22E457D4D82BQ27027598-07C07209-75C6-4B17-964F-841994C8A123Q28568570-9795DF46-2084-420A-B2F1-C0493C7574D4Q30575703-0BDC255D-840F-4C61-AE4C-839EFB6A6399Q33576938-7CF5C632-EBAF-4E5D-991A-37852D75AFE3Q33623924-7E499199-A07C-4C4E-A9DA-E4DACFCB3AABQ33915170-ECD83756-0F2E-40EE-8B67-29B770922582Q33939101-4FA6D1C3-28F6-4F3C-B222-1B42EC9E7654Q33999164-0A714ACC-1941-4E00-9EB2-A89E73E9C281Q34091893-456A5065-296F-4C34-9F7B-04300DF990B7Q34504328-3237F942-487D-4BFC-B9F5-31F7194D3382Q34959106-58C58E9D-3F2E-4412-9F69-46752C753058Q35128532-935028F1-CC01-4724-AF21-F6BAB2D21B01Q35592722-CBCE46F8-FE6A-4FCD-A5C7-4BB25B6AAD6AQ35690343-B9C0CF01-8665-4700-9368-A803395D8D7BQ35748499-38C74B41-2142-4738-9EEE-A0A73686719AQ35852422-0634B1A5-61B4-48F0-9CC4-03E88D9039DFQ36063538-868AD344-6C6E-47C6-AC86-0E1A4D8519B1Q36102891-182650D8-6AA4-48C9-97CC-298E23CF7BE0Q36130681-314046D2-ECC6-4EEC-93ED-23C56F6480B1Q36436653-4596DAF9-4C15-41FC-A9D2-A0D3BA89010AQ36543895-7615395B-3AF6-4228-AFAA-EE5ADFED540DQ36713951-166D7E53-5398-4342-AF69-74A5C39DFC8BQ36847461-CA8412F8-12D0-4B91-8DF0-AB5DF2AADE79Q37036997-5C4277F5-CEDC-4BB7-8535-579561B7B0D7Q37084126-F92C0E85-E0D4-4E08-B652-A04EADC116F6Q37120749-D448D5DC-0FE4-46A5-A49D-3F3F0CE1A4C9Q37179119-57C23FE5-9AF1-4757-92BB-C8E36F24F5A9Q37203370-A7903E21-36E6-4408-A7CF-EEB9736FBA81Q37204144-BDA7C1BC-660E-4F9C-86B4-51D0896691D0Q37205120-F364C612-968D-498D-9EBE-D9ADD744647DQ37219312-4E947CE5-C524-4136-9DCB-EE6172B4C93CQ37246161-83E322AE-C38E-4B52-81D9-726491D96EA5Q37335851-CFE1D1EC-03EE-4E52-93EB-1DD724BF560CQ37417117-31EAB813-F018-472A-9E84-905CDEFC6A00Q37972068-1D3454A2-8002-4536-B201-A713050F56F5Q37995980-4C79EB24-EA7F-4C79-9EF8-B8E1320A8992
P2860
Low free testosterone is an independent risk factor for Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Low free testosterone is an independent risk factor for Alzheimer's disease.
@ast
Low free testosterone is an independent risk factor for Alzheimer's disease.
@en
Low free testosterone is an independent risk factor for Alzheimer's disease.
@nl
type
label
Low free testosterone is an independent risk factor for Alzheimer's disease.
@ast
Low free testosterone is an independent risk factor for Alzheimer's disease.
@en
Low free testosterone is an independent risk factor for Alzheimer's disease.
@nl
prefLabel
Low free testosterone is an independent risk factor for Alzheimer's disease.
@ast
Low free testosterone is an independent risk factor for Alzheimer's disease.
@en
Low free testosterone is an independent risk factor for Alzheimer's disease.
@nl
P1476
Low free testosterone is an independent risk factor for Alzheimer's disease
@en
P2093
Bandelow S
Combrinck M
P304
P356
10.1016/J.EXGER.2004.06.019
P577
2004-11-01T00:00:00Z